Paul G. Pavicic

机构：Cleveland Clinic · ORCID：0000-0002-5772-3192

发表论文 94 篇 · 总被引 1272 次 · h-index 16

代表论文

AI-informed computational pathology classifier predicts outcomes across treatment modalities in muscle-invasive urothelial carcinoma (2025 · Cancer Letters · 被引 4)
Responses to checkpoint inhibition in metastatic triple negative breast cancer driven by divergent myeloid phenotypes (2025 · Communications Medicine · 被引 2)
Genomic correlates of response and resistance to immune checkpoint inhibitors (ICI) in patients with metastatic urothelial carcinoma (mUC) in a real-world setting. (2024 · Journal of Clinical Oncology · 被引 2)
Effect of neutrophil to lymphocyte ratio (NLR) on outcomes with immune checkpoint inhibitors (ICIs) in patients (pts) with metastatic urothelial carcinoma (mUC) in real-world setting. (2024 · Journal of Clinical Oncology · 被引 2)
546 AI-informed features of the spatial architecture of tumor-infiltrating lymphocytes predict the benefit of immune checkpoint inhibitors in urothelial cancer (2024 · Regular and Young Investigator Award Abstracts · 被引 1)
Effect of body mass index (BMI) on efficacy of immune checkpoint inhibitors (ICIs) in patients with metastatic urothelial carcinoma (mUC) in real-world setting. (2024 · Journal of Clinical Oncology · 被引 1)